These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 29750532)

  • 1. Proteomic Analysis and NIR-II Imaging of MCM2 Protein in Hepatocellular Carcinoma.
    Yang J; Xie Q; Zhou H; Chang L; Wei W; Wang Y; Li H; Deng Z; Xiao Y; Wu J; Xu P; Hong X
    J Proteome Res; 2018 Jul; 17(7):2428-2439. PubMed ID: 29750532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients.
    Tang Z; Yang Y; Chen W; Li E; Liang T
    J Transl Med; 2022 Jan; 20(1):49. PubMed ID: 35093119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minichromosome maintenance protein 2 and 3 promote osteosarcoma progression via DHX9 and predict poor patient prognosis.
    Cheng DD; Zhang HZ; Yuan JQ; Li SJ; Yang QC; Fan CY
    Oncotarget; 2017 Apr; 8(16):26380-26393. PubMed ID: 28460433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MCM2-regulated functional networks in lung cancer by multi-dimensional proteomic approach.
    Cheung CHY; Hsu CL; Chen KP; Chong ST; Wu CH; Huang HC; Juan HF
    Sci Rep; 2017 Oct; 7(1):13302. PubMed ID: 29038488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. System biology analysis of cell cycle pathway involved in hepatocellular carcinoma.
    Sun M; Mo W; Fu X; Wu G; Huang Y; Tang R; Guo Y; Qiu M; Zhao F; Li L; Huang S; Mao Y; Li Y; Xie Y
    Front Biosci (Schol Ed); 2010 Jun; 2(3):1127-44. PubMed ID: 20515845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression.
    Liu Z; Li J; Chen J; Shan Q; Dai H; Xie H; Zhou L; Xu X; Zheng S
    BMC Cancer; 2018 Feb; 18(1):200. PubMed ID: 29463213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.
    Hernandez R; Sun H; England CG; Valdovinos HF; Ehlerding EB; Barnhart TE; Yang Y; Cai W
    Theranostics; 2016; 6(11):1918-33. PubMed ID: 27570560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a.
    Liu F; Yuan JH; Huang JF; Yang F; Wang TT; Ma JZ; Zhang L; Zhou CC; Wang F; Yu J; Zhou WP; Sun SH
    Oncogene; 2016 Oct; 35(41):5422-5434. PubMed ID: 27065331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCM2 mediates progesterone-induced endometrial stromal cell proliferation and differentiation in mice.
    Kong S; Han X; Cui T; Zhou C; Jiang Y; Zhang H; Wang B; Wang H; Zhang S
    Endocrine; 2016 Aug; 53(2):595-606. PubMed ID: 26910396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ITRAQ-based quantitative proteomic analysis reveals that VPS35 promotes the expression of MCM2-7 genes in HeLa cells.
    Hong X; Wang T; Du J; Hong Y; Yang CP; Xiao W; Li Y; Wang M; Sun H; Deng ZH
    Sci Rep; 2022 Jun; 12(1):9700. PubMed ID: 35690672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of Slit3 induces tumor proliferation and chemoresistance in hepatocellular carcinoma through activation of GSK3β/β-catenin pathway.
    Ng L; Chow AKM; Man JHW; Yau TCC; Wan TMH; Iyer DN; Kwan VHT; Poon RTP; Pang RWC; Law WL
    BMC Cancer; 2018 Jun; 18(1):621. PubMed ID: 29859044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Direct Interaction Between P53-Binding Protein 1 and Minichromosome Maintenance Complex in Hepg2 Cells.
    Chen Y; Weng C; Zhang H; Sun J; Yuan Y
    Cell Physiol Biochem; 2018; 47(6):2350-2359. PubMed ID: 29990989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative proteomics reveal up-regulated protein expression of the SET complex associated with hepatocellular carcinoma.
    Li C; Ruan HQ; Liu YS; Xu MJ; Dai J; Sheng QH; Tan YX; Yao ZZ; Wang HY; Wu JR; Zeng R
    J Proteome Res; 2012 Feb; 11(2):871-85. PubMed ID: 22082227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nek7 is overexpressed in hepatocellular carcinoma and promotes hepatocellular carcinoma cell proliferation in vitro and in vivo.
    Zhou L; Wang Z; Xu X; Wan Y; Qu K; Fan H; Chen Q; Sun X; Liu C
    Oncotarget; 2016 Apr; 7(14):18620-30. PubMed ID: 26921196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nascent transcription of MCM2-7 is important for nuclear localization of the minichromosome maintenance complex in G1.
    Braun KA; Breeden LL
    Mol Biol Cell; 2007 Apr; 18(4):1447-56. PubMed ID: 17314407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinoma.
    Jiang C; Long J; Liu B; Xu M; Wang W; Xie X; Wang X; Kuang M
    J Exp Clin Cancer Res; 2017 Jul; 36(1):99. PubMed ID: 28750679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optical Imaging of Mesenchymal Epithelial Transition Factor (MET) for Enhanced Detection and Characterization of Primary and Metastatic Hepatic Tumors.
    Esfahani SA; Heidari P; Kim SA; Ogino S; Mahmood U
    Theranostics; 2016; 6(12):2028-2038. PubMed ID: 27698938
    [No Abstract]   [Full Text] [Related]  

  • 18. MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas.
    Zhang X; Teng Y; Yang F; Wang M; Hong X; Ye LG; Gao YN; Chen GY
    Oncol Rep; 2015 May; 33(5):2599-605. PubMed ID: 25738322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
    Chen B; Wei W; Ma L; Yang B; Gill RM; Chua MS; Butte AJ; So S
    Gastroenterology; 2017 Jun; 152(8):2022-2036. PubMed ID: 28284560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.